2025 - Introduced
Illinois S.B.1238
  • Prohibits a health insurer from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, health insurers must ensure a non-opioid is not disadvantaged or discouraged with respect to coverage of an opioid. The bill also allows the Illinois Department of Public Health to develop and publish non-opioid educational resources.
Medicaid ParityState Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Indiana H.B. 1358
  • Prohibits stricter coverage restrictions under Medicaid and the Children’s Health Insurance Program for FDA-approved non-opioids compared to opioids to treat or manage pain. The bill also prohibits health insurers and health maintenance organization contracts from applying greater coverage restrictions on non-opioid prescribed drugs than to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Iowa HSF 151
  • Requires that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to Medicaid coverage relative to an opioid on the preferred drug list.
  • Prohibits health insurers from establishing utilization controls for non-opioid drugs approved by the FDA that are more restrictive or extensive than the least restrictive or extensive utilization controls for any opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2024 - Passed
Maine L.D. 2096
  • Requires health insurers develop and submit a plan to the Maine Bureau of Insurance for review and approval of the inclusion of non-opioid pain management services and treatments. Upon approval, insurers must develop and disseminate related educational materials.
State Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Maryland H.B. 1013/S.B. 974
  • Prohibits prior authorization requirements, step therapy protocol, or fail-first protocol for a non-opioid that is more restrictive than requirements for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill
2024 - Passed
Massachusetts H.5142
  • Requires health insurers to cover non-opioid medications without favoring opioids over non-opioids.
  • Requires the Massachusetts Department of Health create educational materials about non-opioid treatments for use at pharmacies, as well as develop new provider training requirements regarding non-opioid alternatives for pain treatment.
State Regulated Commercial ParityProvider Education
Read Bill
2025 - Introduced
Minnesota S.F. 1946
  • Requires health insurers cover non-opioid treatments and prohibits utilization controls that are more restrictive or extensive than the least restrictive or extensive utilization controls for opioids. Also requires health insurers to distribute non-opioid educational materials to in-network providers and enrollees and to publish resources on the health plan company's website.
State Regulated Commercial ParityProvider Education
Read Bill
2025 - Introduced
Missouri S.B.158
  • For enrollees with an increased risk of opioid abuse, prohibits health insurers from: (1) denying coverage for non-opioid prescription drugs in favor of opioid drugs; (2) requiring an enrollee try an opioid prescription drug prior to approving the use of a non-opioid prescription drug; or (3) requiring a higher cost-sharing for non-opioid prescription drugs.
State Regulated Commercial Parity
Read Bill
2025 - Introduced
Montana H.B. 774
  • Prohibits Medicaid and health insurers from denying coverage of a non-opioid in favor of an opioid and requires that in establishing a drug formulary, the Montana Department of Public Health and Human Services must ensure a non-opioid is not disadvantaged or discouraged as compared to coverage of an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nebraska L.B.252 
  • Prohibits Medicaid and health insurers from imposing restrictive practices that disadvantage or discourage the use of non-opioid drugs for the treatment of pain relative to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Nevada S.B. 377
  • Requires health insurers and Medicaid cover at least one alternative to an opioid and prohibits insurers from requiring prior authorization or other restrictive requirements for an alternative to an opioid compared to requirements established for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
New Hampshire H.B.241
  • Requires commercial insurers establish parity for non-opioid treatments and therapies.
State Regulated Commercial Parity
Read Bill